Clinical trial
Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable…
NCT00238602 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00238602 |
|---|---|
| Title | Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer |
| Official title | Evaluation of the Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Tumors - A Phase I/II Study |
| Lead sponsor | Stanford University, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Procedure |
| Interventions | Stereotactic radiosurgery |
| Enrollment | 48 |
| Start date | Mar 1, 2000 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2012 |
| First posted | Oct 13, 2005 |
| Last update posted | Jul 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: